Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ENTAENTA
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ENANTA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 464,649 shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $6.8M as of 2026-Q2. The position was increased (+75.3% shares). ENTA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$6.8M

Current Shares

464,649

Total Value Change

+$6.1M

Total Shares Change

+340,788

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
464,649
+75.3%
$6.8M0.0%$14.58
41
2026-Q1
Increased
265,088
+21.1%
$3.3M0.0%$14.72
32
2025-Q4
Increased
218,816
+31.5%
$3.5M0.0%$15.90
34
2025-Q3
Increased
166,433
+43.3%
$2M0.0%$15.16
35
2025-Q2
Decreased
116,135
-10.9%
$877,9810.0%$7.50
0
2025-Q1
Increased
130,410
+5.3%
$719,8630.0%$5.71
26
2024-Q4
New
123,861
-
$712,2010.0%$5.85
34

Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used